Ausgabe 6/2017
Inhalt (15 Artikel)
- Invited Commentary
Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?
Brady L Stein, Srdan Verstovsek
- Invited Commentary
Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond
Naveen Pemmaraju
- Myelodysplastic Syndromes (M Savona, Section Editor)
Models of Prognostication in Chronic Myelomonocytic Leukemia
Francesco Onida
- CART and Immunotherapy (M Ruella, Section Editor)
Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer
Nathan Singh, Junwei Shi, Carl H. June, Marco Ruella
- Acute Myeloid Leukemias (H Erba, Section Editor)
Predicting Chemotherapy Resistance in AML
Cecilia C. S. Yeung, Jerald Radich
- Acute Myeloid Leukemias (H Erba, Section Editor)
Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
Brittany Knick Ragon, Courtney D. DiNardo
- Acute Myeloid Leukemias (H Erba, Section Editor)
The Prognostic Significance of Measurable (“Minimal”) Residual Disease in Acute Myeloid Leukemia
Francesco Buccisano, Christopher S. Hourigan, Roland B. Walter
- Acute Myeloid Leukemias (H Erba, Section Editor)
Methods of Detection of Measurable Residual Disease in AML
Yi Zhou, Brent L. Wood
- Acute Myeloid Leukemias (H Erba, Section Editor)
Diagnostic and Prognostic Utility of Fluorescence In situ Hybridization (FISH) Analysis in Acute Myeloid Leukemia
Patrick R. Gonzales, Fady M. Mikhail
- Acute Myeloid Leukemias (H Erba, Section Editor)
Measurement of Residual Disease in Acute Myeloid Leukemia
Rahul S. Vedula, R. Coleman Lindsley
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?
Aaron T. Gerds, Teresa Chan
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Michael A. Thompson, Andrew A. Lane
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Jean-Jacques Kiladjian, Ruben Mesa, Michael A. Thompson
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Using Social Media at National Meetings in Hematology—Optimal Use, Tips, Strategies, and Limitations
Aaron C. Logan
- Myeloproliferative Neoplasms (B Stein, Section Editor)
Novel Therapies for Myelofibrosis
Kristen Pettit, Olatoyosi Odenike
